美國居民不適用 XM 服務。

India ups ESPO Blend oil purchases in June-July as Chinese demand eases



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>India ups ESPO Blend oil purchases in June-July as Chinese demand eases</title></head><body>

MOSCOW/NEW DELHI, July 17 (Reuters) -India increased its purchases of Russia's Far East ESPO Blend oil for June and July arrival as China, a key buyer of the grade, bought less, two sources involved in the Russian oil trade said and LSEG data showed.

India's imports of Russian ESPO Blend rose to some 500,000 metric tons (123,000 barrels per day) in June and are expected to surpass 700,000 tons this month, according to the sources and the data. This is a significant rise from the 100,000-200,000 tons of the grade India has been purchasing monthly since September 2023, LSEG data shows.

"India's refiners increased ESPO Blend oil buying last month as ample supplies and weaker Chinese demand allowed them to purchase cargoes at a lower price," one of the sources said.

Indian refiners Reliance Industries and Indian Oil were the country's main buyers of ESPO Blend oil last month, the sources said, citing data.

India is the largest buyer of seaborne Russian flagship Urals oil, while China is the main buyer of ESPO Blend due to its suitability for the country's smaller "teapot" refiners and the close proximity of Russia's Kozmino port to China.

China's demand for ESPO Blend fell for May-early June loading cargoes as weak refining margins led to wider discounts for the grade, but prices have improved for July and August loading volumes on stockpiling demand.




Reporting by Reuters in Moscow and Nidhi Verma in New Delhi ; Editing by Kirsten Donovan

</body></html>

免責聲明: XM Group提供線上交易平台的登入和執行服務,允許個人查看和/或使用網站所提供的內容,但不進行任何更改或擴展其服務和訪問權限,並受以下條款與條例約束:(i)條款與條例;(ii)風險提示;(iii)完全免責聲明。網站內部所提供的所有資訊,僅限於一般資訊用途。請注意,我們所有的線上交易平台內容並不構成,也不被視為進入金融市場交易的邀約或邀請 。金融市場交易會對您的投資帶來重大風險。

所有缐上交易平台所發佈的資料,僅適用於教育/資訊類用途,不包含也不應被視爲適用於金融、投資稅或交易相關諮詢和建議,或是交易價格紀錄,或是任何金融商品或非應邀途徑的金融相關優惠的交易邀約或邀請。

本網站的所有XM和第三方所提供的内容,包括意見、新聞、研究、分析、價格其他資訊和第三方網站鏈接,皆爲‘按原狀’,並作爲一般市場評論所提供,而非投資建議。請理解和接受,所有被歸類為投資研究範圍的相關内容,並非爲了促進投資研究獨立性,而根據法律要求所編寫,而是被視爲符合營銷傳播相關法律與法規所編寫的内容。請確保您已詳讀並完全理解我們的非獨立投資研究提示和風險提示資訊,相關詳情請點擊 這裡查看。

風險提示:您的資金存在風險。槓桿商品並不適合所有客戶。請詳細閱讀我們的風險聲明